Rasonque

News

The RAS inhibitor for pancreatic cancer that received a standing ovation at ASCO for its doubling of overall survival now has its FDA approval.

News

Pharmacy now represents 25% of employer healthcare spending, and employers are turning to DTC models and nontraditional PBMs to cut costs.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.